CTCF and breast cancer: To investigate the clinical significance of CTCF downregulation in breast cancer, we analyzed the potential association between CTCF levels and clinical characteristics of paraffin-embedded breast cancer tissue specimens obtained from 66 patients (17, 24, and 25 cases at stage I, II, and III/IV, respectively) (Table 1).